NCT05908266 Flexible Reaching Control in Parkinson Disease
| NCT ID | NCT05908266 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université Catholique de Louvain |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2027-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-05-01 with a primary completion date of 2027-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Current research and theories have highlighted that the parameters linked to movement planning, e.g. the decision to select a movement goal, and adaptation, e.g. the ability to update control dependent on a novel dynamical context, are update quickly and within an ongoing movement in the general population. In parallel, it has been suggested that the evaluation of movement costs is a function of the basal ganglia, and it is impaired in Parkinson disease (PD). Here the investigators want to test whether these mechanisms also alter the ability of patients to update control during an ongoing action. A positive result would confirm that movement-related costs and dynamical representations depend on the integrity of the basal ganglia, in contrast a negative result would indicate that the deficit in PD is more specifically related to movement initiation, which would invite one to reconsider the cause of bradykinesia in this population.
Eligibility Criteria
Inclusion Criteria: * Ability to perform the task (assessed during the experiment) Exclusion Criteria: * Inability to perform the task (motor) or to understand the task requirements (cognitive)
Contact & Investigator
Frédéric Crevecoeur, PhD
STUDY DIRECTOR
Université Catholique de Louvain
Frequently Asked Questions
Who can join the NCT05908266 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05908266 currently recruiting?
Yes, NCT05908266 is actively recruiting participants. Contact the research team at andre.mouraux@uclouvain.be for enrollment information.
Where is the NCT05908266 trial being conducted?
This trial is being conducted at Louvain-la-Neuve, Belgium.
Who is sponsoring the NCT05908266 clinical trial?
NCT05908266 is sponsored by Université Catholique de Louvain. The principal investigator is Frédéric Crevecoeur, PhD at Université Catholique de Louvain. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.